print this page

Over-The-Counter Strategic Services

Prescription to over-the-counter (OTC) switches and direct to OTC approvals are complex initiatives that can raise regulatory, scientific, commercial, and policy concerns, and involve the sometimes conflicting interests of multiple stakeholders.  Pinney Associates' experience in supporting prescription to OTC switches, direct to OTC approvals, and existing OTC products enables us to provide comprehensive support throughout the product lifecycle from clinical development, to preparation for regulatory submissions and FDA Advisory Committee meetings, to marketing and post-marketing clinical and regulatory guidance.

Our teams support clients' research and development, commercial, and regulatory functions.  Most importantly, our Issues Management process helps clients to create or amend a Drug Facts label, shape the New Drug Application, prepare for FDA Advisory Committee meetings, and address the concerns of key stakeholders.

Specific services Pinney Associates provides in support of OTC products include: